It's Meseidy

It's Meseidy

Share this post

It's Meseidy
It's Meseidy
Big Bite: Biden demands insurance companies cover medical "gender-affirming care" after the FDA added a warning to puberty blockers
Copy link
Facebook
Email
Notes
More

Big Bite: Biden demands insurance companies cover medical "gender-affirming care" after the FDA added a warning to puberty blockers

Big bite | A detailed dive into big news

Meseidy's avatar
Meseidy
Aug 02, 2022
∙ Paid

Share this post

It's Meseidy
It's Meseidy
Big Bite: Biden demands insurance companies cover medical "gender-affirming care" after the FDA added a warning to puberty blockers
Copy link
Facebook
Email
Notes
More
Share
person holding white printer paper
Photo by Alexander Grey on Unsplash

July 1

On July 1, the Food and Drug Administration (FDA) added a warning to multiple gonadotropin-releasing hormone (GnRH) agonists, drugs often used as puberty blockers in gender-confused youth.

The FDA identified six cases where there was a “plausible” link between GnRH agonists and a condition called pseudotumor cerebri, which is caused by elevated fluid pressure in the brain.

According to the FDA, all six cases were identified in biologically female children between the ages of 5 and 12; five of the six were being treated for early puberty, and the sixth was undergoing “transgender care.”

According to the Daily Wire, symptoms included specifically, “visual disturbances, headaches, and vomiting.” In addition, “Other effects GnRH agonists caused were an increase in blood pressure, brain swelling, and abducens neuropathy.”

July 18

On July 18, a clip of Biden's Assistant Secretary for Health Rachel Levine speaking about youth gender affirmation treatment w…

Keep reading with a 7-day free trial

Subscribe to It's Meseidy to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Meseidy Rivera
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More